Inspire Medical Systems (INSP) Tops Q3 EPS by 54c, increases guidance

Inspire Medical Systems (NYSE: INSP) reported Q3 EPS of $0.60, $0.54 better than the analyst estimate of $0.06. Revenue for the quarter came in at $203.2 million versus the consensus estimate of $197.59 million.

GUIDANCE:

Inspire Medical Systems sees FY2024 EPS of $1.20-$1.40, versus the consensus of $0.74. Inspire Medical Systems sees FY2024 revenue of $793-798 million, versus the consensus of $795.1 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Stardust Solar closes final tranche, raises $832,880 in total
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance